Safeguarding Biopharmas From Product Shortages

By Brad John and Marcos Perez

Over the last few years, businesses have learned difficult lessons about the effects of supply chain weaknesses and the importance of solving them. The COVID-19 pandemic is just one example of the types of supply chain disruptions that life sciences companies faced. It is important to understand there are key considerations that can help life sciences businesses prepare for and respond to product shortages.